Physician

Carl Joseph Minniti, MD

According to 2025 Medicare claims, Carl Minniti, MD (NPI: 1811993652) practices medical oncology in the Camden, NJ market, with the plurality of this provider's patient population coming from Gloucester, NJ. This provider's primary affiliated billing organization is THE MINNITI CENTER FOR MEDICAL ONCOLOGY AND HEMATOLOGY (NPI: 1831234954; TIN: 221929064) and primary practice location at 08056-1236.

Minniti's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 517 traditional Medicare patients, billed 165,014 HCPCS/CPT codes, and received $2,569,653 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,321 prescription claims across 214 beneficiaries totaling $4,276,281 in drug costs, led by Brukinsa (Zanubrutinib). DME data shows 265 claims. Open Payments data shows 11 records totaling $95,367. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $760,363 to $4,276,281. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $19,336 to $6,515.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	619	161,978	$2,107,419
2016	641	248,032	$2,216,080
2017	651	191,060	$2,079,618
2018	636	201,933	$2,326,351
2019	587	177,627	$2,250,605
2020	517	235,503	$3,288,514
2021	491	191,026	$2,557,681
2022	495	214,905	$2,191,101
2023	481	225,492	$2,803,024
2024	517	165,014	$2,569,653

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	168	803	$760,363
2016	169	999	$1,247,394
2017	162	954	$1,539,375
2018	181	1,057	$2,178,146
2019	193	1,147	$2,420,316
2020	197	1,151	$2,276,564
2021	171	871	$1,094,127
2022	158	870	$1,572,510
2023	165	1,039	$2,877,727
2024	214	1,321	$4,276,281

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	76	474	$20,389
2016	77	403	$14,179
2017	N/R	229	$8,833
2018	67	271	$12,257
2019	N/R	348	$40,125
2020	62	486	$55,853
2021	55	342	$14,665
2022	N/R	220	$7,475
2023	N/R	348	$16,260
2024	N/R	265	$34,000

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	210	565	$153
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	308	655	$103
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	160	300	$68
36415	Insertion of needle into vein for collection of blood sample	384	1,505	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	383	1,488	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brukinsa	Zanubrutinib	43	1,290	$603,580
Lenalidomide	Lenalidomide	39	1,092	$578,728
Calquence	Acalabrutinib Maleate	25	750	$373,460
Revlimid	Lenalidomide	16	448	$353,966
Cabometyx	Cabozantinib S-Malate	13	390	$324,679

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4193	Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 52 to 73 grams of protein - premix	N	N/R	11	$17,349
B4185	Parenteral nutrition solution, not otherwise specified, 10 grams lipids	N	N/R	20	$5,601
E0781	Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient	Y	N/R	14	$2,751
B4224	Parenteral nutrition administration kit, per day	N	N/R	20	$2,721
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	60	$2,182

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$3,381	BeiGene USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	6	$91,985	Amgen Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Carl Joseph Minniti, MD?

Tedicare shows public-source Medicare data for Carl Joseph Minniti, MD (NPI 1811993652), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carl Joseph Minniti, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Carl Joseph Minniti, MD?

Carl Joseph Minniti, MD is linked to THE MINNITI CENTER FOR MEDICAL ONCOLOGY AND HEMATOLOGY (billing NPI 1831234954) in the available physician profile data.

Does Carl Joseph Minniti, MD have Open Payments data?

Carl Joseph Minniti, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.